A modified BPaL regimen for tuberculosis treatment replaces linezolid with inhaled spectinamides

The Nix-TB clinical trial evaluated a new 6 month regimen containing three oral drugs; bedaquiline (B), pretomanid (Pa), and linezolid (L) (BPaL regimen) for the treatment of tuberculosis (TB). This regimen achieved remarkable results as almost 90% of the multidrug-resistant or extensively drug-resi...

Descripció completa

Dades bibliogràfiques

Autors principals:	Malik Zohaib Ali, Taru S Dutt, Amy MacNeill, Amanda Walz, Camron Pearce, Ha Lam, Jamie S Philp, Johnathan Patterson, Marcela Henao-Tamayo, Richard Lee, Jiuyu Liu, Gregory T Robertson, Anthony J Hickey, Bernd Meibohm, Mercedes Gonzalez Juarrero
Format:	Artigo
Idioma:	Inglês
Publicat:	eLife Sciences Publications Ltd 2024-10-01
Col·lecció:	eLife
Matèries:	Mycobacterium tuberculosis inhalation spectinmaides linezolid bedaquiline/pretomanid
Accés en línia:	https://elifesciences.org/articles/96190
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!